263 related articles for article (PubMed ID: 37371048)
1. scRNA-Seq of Cultured Human Amniotic Fluid from Fetuses with Spina Bifida Reveals the Origin and Heterogeneity of the Cellular Content.
Dasargyri A; González Rodríguez D; Rehrauer H; Reichmann E; Biedermann T; Moehrlen U
Cells; 2023 Jun; 12(12):. PubMed ID: 37371048
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of amniotic fluid of pregnant rats with spina bifida aperta.
Shan L; Fan Y; Li H; Liu W; Gu H; Zhou F; Yuan Z
J Proteomics; 2012 Feb; 75(4):1181-9. PubMed ID: 22108047
[TBL] [Abstract][Full Text] [Related]
3. Intra-amniotic transplantation of brain-derived neurotrophic factor-modified mesenchymal stem cells treatment for rat fetuses with spina bifida aperta.
Ma W; Wei X; Gu H; Liu D; Luo W; Cao S; Jia S; He Y; Chen L; Bai Y; Yuan Z
Stem Cell Res Ther; 2022 Aug; 13(1):413. PubMed ID: 35964077
[TBL] [Abstract][Full Text] [Related]
4. Are myo-inositol, glucose and zinc concentrations in amniotic fluid of fetuses with spina bifida different from controls?
Groenen PM; Wevers RA; Janssen FS; Tuerlings JH; Merkus JM; Steegers-Theunissen RP
Early Hum Dev; 2003 Feb; 71(1):1-8. PubMed ID: 12614945
[TBL] [Abstract][Full Text] [Related]
5. Intra-amniotic mesenchymal stem cell therapy improves the amniotic fluid microenvironment in rat spina bifida aperta fetuses.
Wei X; Ma W; Gu H; Liu D; Luo W; Cao S; Jia S; Huang T; He Y; Bai Y; Wang W; Yuan Z
Cell Prolif; 2023 Feb; 56(2):e13354. PubMed ID: 36266504
[TBL] [Abstract][Full Text] [Related]
6. Application potential of bone marrow mesenchymal stem cell (BMSCs) based tissue-engineering for spinal cord defect repair in rat fetuses with spina bifida aperta.
Li X; Yuan Z; Wei X; Li H; Zhao G; Miao J; Wu D; Liu B; Cao S; An D; Ma W; Zhang H; Wang W; Wang Q; Gu H
J Mater Sci Mater Med; 2016 Apr; 27(4):77. PubMed ID: 26894267
[TBL] [Abstract][Full Text] [Related]
7. Intra-amniotic delivery of amniotic-derived neural stem cells in a syngeneic model of spina bifida.
Turner CG; Pennington EC; Gray FL; Ahmed A; Teng YD; Fauza DO
Fetal Diagn Ther; 2013; 34(1):38-43. PubMed ID: 23635813
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of transamniotic stem cell therapy for spina bifida by genetic engineering of donor mesenchymal stem cells with an Fgf2 transgene.
Lazow SP; Labuz DF; Kycia I; Zurakowski D; Fauza DO
J Pediatr Surg; 2021 Jun; 56(6):1226-1232. PubMed ID: 33771369
[TBL] [Abstract][Full Text] [Related]
9. Partial or complete coverage of experimental spina bifida by simple intra-amniotic injection of concentrated amniotic mesenchymal stem cells.
Dionigi B; Ahmed A; Brazzo J; Connors JP; Zurakowski D; Fauza DO
J Pediatr Surg; 2015 Jan; 50(1):69-73. PubMed ID: 25598096
[TBL] [Abstract][Full Text] [Related]
10. Transfection of STAT3 overexpression plasmid mediated through recombinant lentivirus promotes differentiation of bone marrow mesenchymal stem cells into neural cells in fetal rats with spina bifida aperta.
Jiang M; Feng J; Fu R; Pan Y; Liu X; Dai J; Jiang C; Hao Y; Ren M
Aging (Albany NY); 2021 Sep; 13(17):21778-21790. PubMed ID: 34520395
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of adenovirus-encoding brain-derived neurotrophic factor for spina bifida aperta by intra-amniotic delivery in a rat model.
Ma W; Wei X; Gu H; Liu D; Luo W; An D; Bai Y; Yuan Z
Gene Ther; 2020 Dec; 27(12):567-578. PubMed ID: 32094517
[TBL] [Abstract][Full Text] [Related]
12. The role of amino acids in spina bifida.
Kale A; Kale E
Clin Exp Obstet Gynecol; 2012; 39(3):374-5. PubMed ID: 23157048
[TBL] [Abstract][Full Text] [Related]
13. CD200-CD200R imbalance correlates with microglia and pro-inflammatory activation in rat spinal cords exposed to amniotic fluid in retinoic acid-induced spina bifida.
Oria M; Figueira RL; Scorletti F; Sbragia L; Owens K; Li Z; Pathak B; Corona MU; Marotta M; Encinas JL; Peiro JL
Sci Rep; 2018 Jul; 8(1):10638. PubMed ID: 30006626
[TBL] [Abstract][Full Text] [Related]
14. A comparison between placental and amniotic mesenchymal stem cells for transamniotic stem cell therapy (TRASCET) in experimental spina bifida.
Feng C; D Graham C; Connors JP; Brazzo J; Zurakowski D; Fauza DO
J Pediatr Surg; 2016 Jun; 51(6):1010-3. PubMed ID: 27013425
[TBL] [Abstract][Full Text] [Related]
15. Amniotic fluid-derived stem cell potential for therapeutic and surgical use: A review of the literature.
Baughn C; Campion S; Elbabaa S
Prenat Diagn; 2022 Feb; 42(2):157-163. PubMed ID: 35001398
[TBL] [Abstract][Full Text] [Related]
16. Transamniotic stem cell therapy (TRASCET) in a rabbit model of spina bifida.
Shieh HF; Tracy SA; Hong CR; Chalphin AV; Ahmed A; Rohrer L; Zurakowski D; Fauza DO
J Pediatr Surg; 2019 Feb; 54(2):293-296. PubMed ID: 30518492
[TBL] [Abstract][Full Text] [Related]
17. Trans-amniotic stem cell therapy (TRASCET) minimizes Chiari-II malformation in experimental spina bifida.
Dionigi B; Brazzo JA; Ahmed A; Feng C; Wu Y; Zurakowski D; Fauza DO
J Pediatr Surg; 2015 Jun; 50(6):1037-41. PubMed ID: 25929798
[TBL] [Abstract][Full Text] [Related]
18. Bioengineering of Fetal Skin: Differentiation of Amniotic Fluid Stem Cells into Keratinocytes.
Basler M; Pontiggia L; Biedermann T; Reichmann E; Meuli M; Mazzone L
Fetal Diagn Ther; 2020; 47(3):198-204. PubMed ID: 31509837
[TBL] [Abstract][Full Text] [Related]
19. Donor mesenchymal stem cell linetics after transamniotic stem cell therapy (TRASCET) for experimental spina bifida.
Shieh HF; Ahmed A; Rohrer L; Zurakowski D; Fauza DO
J Pediatr Surg; 2018 Jun; 53(6):1134-1136. PubMed ID: 29580785
[TBL] [Abstract][Full Text] [Related]
20. Raman spectroscopy analysis of human amniotic fluid cells from fetuses with myelomeningocele.
Pontiggia L; Michalak-Micka K; Hürlimann N; Yosef HK; Böni R; Klar AS; Ehrbar M; Ochsenbein-Kölble N; Biedermann T; Moehrlen U
Exp Cell Res; 2024 Jun; 439(1):114048. PubMed ID: 38697275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
